Integrase Strand Transfer Inhibitors

GPTKB entity

Statements (49)
Predicate Object
gptkbp:instanceOf antiretroviral drug class
gptkbp:abbreviation gptkb:INSTIs
gptkbp:approvalYear 2007
gptkbp:approvedBy gptkb:FDA
gptkbp:availableOn global
gptkbp:category antiviral drugs
HIV integrase inhibitors
HIV/AIDS drugs
gptkbp:combinationTherapy often used with NNRTIs
often used with NRTIs
often used with protease inhibitors
gptkbp:contraindication hypersensitivity to drug
gptkbp:cost varies by region and drug
gptkbp:discoveredBy gptkb:Merck_(raltegravir)
gptkbp:drugClass gptkb:cabotegravir
gptkb:dolutegravir
gptkb:elvitegravir
gptkb:raltegravir
bictegravir
gptkbp:drugInteraction gptkb:rifampin
gptkb:carbamazepine
antacids
gptkbp:effect high barrier to resistance (newer agents)
gptkbp:eliminatedIn urine
feces
gptkbp:hasApprovedDrug gptkb:raltegravir
https://www.w3.org/2000/01/rdf-schema#label Integrase Strand Transfer Inhibitors
gptkbp:legalStatus varies by drug
gptkbp:mechanismOfAction inhibit HIV integrase enzyme
gptkbp:metabolism liver
gptkbp:otherDrugs gptkb:cabotegravir
gptkb:dolutegravir
gptkb:elvitegravir
bictegravir
gptkbp:pregnancyCategory consult specific drug
gptkbp:prevention integration of viral DNA into host genome
gptkbp:resistantTo possible with mutations in integrase gene
gptkbp:routeOfAdministration oral
injectable
gptkbp:sideEffect nausea
headache
weight gain
insomnia
gptkbp:target gptkb:HIV-1_integrase
gptkb:HIV-2_integrase
gptkbp:usedFor HIV treatment
gptkbp:WHOStatus included in WHO Model List of Essential Medicines
gptkbp:bfsParent gptkb:INSTIs
gptkbp:bfsLayer 5